Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Quilizumab in Allergen-Induced Airway Obstruction in Mild Asthma
NCT01196039Phase 2Completed
- Sponsor
- Genentech
- Start
- Dec 2010
- Primary completion
- Aug 2011
- Modality
- Monoclonal Antibodies
- Countries
- 2
01
Overview
A Phase 2 trial of quilizumab in allergic asthma, sponsored by Genentech. Started Dec 2010; status: completed.
02
Drugs
quilizumab
03
Conditions
allergic asthma
Beyond the preview
Go deeper on NCT01196039.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01196039.